tolonium chloride has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC | 1 |
| Miller, GW; Rho, O | 1 |
1 review(s) available for tolonium chloride and Parkinson Disease
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate | 2013 |
1 other study(ies) available for tolonium chloride and Parkinson Disease
| Article | Year |
|---|---|
Laser capture microdissection to examine transporter expression in specific cell regions.
Topics: Coloring Agents; Dissection; Humans; Immunohistochemistry; Lasers; Membrane Transport Proteins; Micromanipulation; Neurons; Parkinson Disease; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tissue Distribution; Tolonium Chloride | 2003 |